Edition:
India

Corbus Pharmaceuticals Holdings Inc (CRBP.OQ)

CRBP.OQ on NASDAQ Stock Exchange Global Market

7.00USD
21 Nov 2017
Change (% chg)

-- (--)
Prev Close
$7.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
105,842
52-wk High
$10.50
52-wk Low
$5.35

Select another date:

Wed, Nov 8 2017

BRIEF-Corbus Pharmaceuticals Q3 loss per share $0.14

* Corbus Pharmaceuticals reports 2017 third quarter financial results and highlights recent corporate and clinical advancements

BRIEF-Corbus Pharma reports improvement in skin conditions in a mid-stage study

* Corbus Pharmaceuticals reports significant improvement in mRSS and other clinical outcomes at 28-weeks in systemic sclerosis open-label extension of phase 2 study

BRIEF-Corbus Pharma prices underwritten public offering of common stock

* Corbus Pharmaceuticals Holdings, Inc. prices underwritten public offering of common stock

BRIEF-Corbus Pharmaceuticals Holdings announces proposed public offering of common stock

* Corbus Pharmaceuticals Holdings Inc announces proposed public offering of common stock

BRIEF-Corbus Pharma's inflammatory disease drug succeeds mid-stage study

* Corbus Pharmaceuticals reports positive topline results from phase 2 study in rare autoimmune disease dermatomyositis

BRIEF-Corbus Pharmaceuticals Holdings reports Q2 loss per share $0.15

* Corbus Pharmaceuticals reports 2017 second quarter financial results and provides business update

BRIEF-Corbus Pharmaceuticals presented data from phase 2 study of anabasum for treatment of systemic sclerosis

* Corbus Pharmaceuticals presented data from phase 2 study of anabasum for the treatment of systemic sclerosis at the eular 2017 annual meeting

Select another date: